IV tPA is a class 1 level A recommendation from the major healthcare scientific organizations who have reviewed the evidence supporting its use. Systems should be in place to insure adherence to recommended standards for Primary Stroke Centers or equivalent State Stroke Designation programs. Every patient or caregiver should have the potential risks and benefits of IV tPA explained prior to therapy whenever possible, and the following written consent form is one example of this. However, delivery of therapy should never be delayed in order to obtain written informed consent.
You will need Acrobat Reader to view forms in PDF format.
Thank you for e-mailing this page.
Thank you for your providing feedback. Your comments will be responded to within an appropriate time frame.
Save & Share this webpage
The MGH Neurology Department placed 4th in
US News Neurology / NeuroSurgery rankings for 2013-14.
Support the Stroke Service
This video simulation of an Emergency stroke evaluation
illustrates the care of patients with acute stroke by the
MGH Acute Stroke team.
Most frequently visited pages
© 2016 Massachusetts General Hospital | 15 Parkman Street Boston, MA. 02114 | (617) 726-8459
Contact Us |
Email the Webmaster